Skip to main content
OpenTrials

Clinical trial condition

Blood Coagulation Disorders

Explore clinical trials studying Blood Coagulation Disorders. Study availability and eligibility vary by location and protocol.

1,481 public trials 252 recruiting studies
Refine in advanced search Browse all conditions

Blood Coagulation Disorders trial results

Completed

Ceprotin Treatment Registry

NCT01127529

Conditions
Blood Coagulation Disorders, Blood Coagulation Disorders, Inherited, Blood Protein Disorders, +6 more
Locations
  • Phoenix, Arizona, United States
  • Orange, California, United States
  • Aurora, Colorado, United States
  • Indianapolis, Indiana, United States
View all 28 locations
View Trial Details
Completed

Retrospective Chart Review to Evaluate Safety and Tolerability of ADVATE Among Previously Untreated Patients in China With Moderate to Severe Hemophilia A

NCT02634723

Conditions
Blood Coagulation Disorders, Blood Coagulation Disorders, Inherited, Coagulation Protein Disorders, +6 more
Locations
  • Institute of Hematology and Oncology, Harbin The First Hospital Harbin, Heilongjiang, China
  • Henan Provincial People's Hospital Zhengzhou, Henan, China
  • Tongji Hospital, Tongji Medical College of Huazhong University of Science & Technology Wuhan, Hubei, China
  • Nanjing Children's Hospital Affiliated to Nanjing Medical University Nanjing, Jiangsu, China
View Trial Details
Completed

Study of Prophylaxis, ACtivity and Effectiveness (SPACE) in Hemophilia Patients Currently Treated With ADVATE or RIXUBIS

NCT02190149

Conditions
Blood Coagulation Disorders, Blood Coagulation Disorders, Inherited, Coagulation Protein Disorders, +8 more
Locations
  • Orthopaedic Hospital DBA Orthopaedic Hemophilia Treatment Center Los Angeles, California, United States
  • Rady Childrens Hospital San Diego, California, United States
  • University of Colorado Aurora, Colorado, United States
  • Bleeding and Clotting Disorders Institute Peoria, Illinois, United States
View all 17 locations
View Trial Details
Completed

Clinical Trial Comparing a Biosimilar Eptacog Alfa With Novoseven, in Patients With Hemophilia With Inhibitors

NCT03935334

Conditions
Blood Coagulation Disorders, Blood Coagulation Disorders, Inherited, Coagulation Protein Disorders, +7 more
Locations
  • Hemophilia Center - Hematology & Oncology Dept. Shiraz University of Medical Science Shiraz, Iran
  • Comprehensive Hemophilia Care Center Tehran, Iran
  • Ali Asghar Hospital Zahedan, Iran
  • Acibadem Adana Hastanesi, Pediatrik Hematoloji-Onkoloji Bölümü Adana, Turkey (Türkiye)
View Trial Details
Completed

Beclomethasone Dipropionate in Preventing Acute Graft-Versus-Host Disease in Patients Undergoing a Donor Stem Cell Transplant for Hematologic Cancer

NCT00489203

Conditions
Accelerated Phase Chronic Myelogenous Leukemia, Adult Acute Lymphoblastic Leukemia in Remission, Adult Acute Myeloid Leukemia With 11q23 (MLL) Abnormalities, +207 more
Locations
  • Hackensack University Medical Center Hackensack, New Jersey, United States
  • Fred Hutchinson Cancer Research Center Seattle, Washington, United States
View Trial Details
Completed

Surveillance of Safety and Efficacy of Wilate in Patients With Von Willebrand Disease

NCT01602419

Conditions
Blood Coagulation Disorders, Blood Coagulation Disorders, Inherited, Blood Platelet Disorders, +8 more
Locations
  • Los Angeles Biomedical Research Institute Torrance, California, United States
  • Nicklaus Children's Hospital Miami, Florida, United States
  • University of Utah Salt Lake City, Utah, United States
  • Virginia Commonwealth University Richmond, Virginia, United States
View all 24 locations
View Trial Details
Completed

Assess the Efficacy and Safety of Personalized Prophylaxis Human-cl rhFVIII in Patients With Severe Haemophilia A

NCT02256917

Conditions
Blood Coagulation Disorders, Blood Coagulation Disorders, Inherited, Coagulation Protein Disorders, +7 more
Locations
  • Octapharma Research Site Sacramento, California, United States
  • Octapharma Research Site Aurora, Colorado, United States
  • Octapharma Research Site Washington D.C., District of Columbia, United States
  • Octapharma Research Site Miami, Florida, United States
View all 30 locations
View Trial Details

Related conditions